![Zura Bio Ltd](/common/images/company/N_ZURA.png)
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. 더 보기
TibuSURE is the first clinical trial designed to investigate anti-BAFF and IL-17 pathways in systemic sclerosis. TibuSURE launches with the initiation of its first clinical site. Zura Bio...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 1.42857142857 | 1.75 | 1.915 | 1.705 | 893115 | 1.76813373 | CS |
4 | -0.395 | -18.202764977 | 2.17 | 2.175 | 1.6 | 534105 | 1.79663398 | CS |
12 | -2.615 | -59.5671981777 | 4.39 | 4.39 | 1.6 | 544236 | 2.35493765 | CS |
26 | -1.885 | -51.5027322404 | 3.66 | 5.07 | 1.6 | 469465 | 3.25855088 | CS |
52 | -1.505 | -45.8841463415 | 3.28 | 6.35 | 1.6 | 381015 | 3.36010968 | CS |
156 | -6.225 | -77.8125 | 8 | 37.55 | 1.6 | 365333 | 5.85570844 | CS |
260 | -6.225 | -77.8125 | 8 | 37.55 | 1.6 | 365333 | 5.85570844 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관